The pancreas has two functional components
The pancreas is really two glands that are intimately mixed together into one organ. The bulk of the pancreas is composed of “exocrine” cells that produce enzymes to help with the digestion of food. These exocrine cells release their enzymes into a series of progressively larger tubes (called ducts) that eventually join together to form the main pancreatic duct. The main pancreatic duct runs the length of the pancreas and drains the fluid produced by the exocrine cells into the duodenum, the first part of the small bowel.
The second functional component of the pancreas is the "endocrine" pancreas. The endocrine pancreas is composed of small islands of cells, called the islets of Langerhans. These endocrine cells don’t release their secretions into the pancreatic ducts, instead they release hormones, such as insulin and glucagon, into the blood stream, and these hormones in turn help control blood sugar (glucose) levels.
Acinar cells are the exocrine (exo=outward) cells of the pancreas that produce and transport enzymes that are passed into the duodenum where they assist in the digestion of food.
|Islets of Langerhans||The islets of Langerhans are the endocrine (endo= within) cells of the pancreas that produce and secrete hormones such as insulin and glucagon into the bloodstream. The pancreatic hormones, insulin and glucagon, work together to maintain the proper level of sugar (glucose) in the blood. Blood sugar is used by the body for energy.|
An understanding of the two functional components of the pancreas is important for two reasons.
First, as they grow large tumors of the pancreas will interfere with both of these important bodily functions. When tumors block the exocrine system, patients can develop pancreatitis and pain from the abnormal release of digestive enzymes into the substance of the pancreas instead of into the bowel, and they can develop digestive problems, such as diarrhea, from the incomplete digestion of food. When tumors destroy the endocrine function of the pancreas, patients can develop sugar diabetes (abnormally high blood sugar levels).
The second reason that the two functional components of the pancreas are important to understand is that tumors can arise in either component. The vast majority of tumors of the pancreas arise in the exocrine part and these cancers look like pancreatic ducts under the microscope. These tumors are therefore called "ductal adenocarcinomas," or simply "adenocarcinoma," or even more simply "pancreatic cancer." Less commonly, tumors arise from the endocrine component of the pancreas and these endocrine tumors are called "pancreatic neuroendocrine tumors," or "islet cell tumors" for short.
How does it all fit together?
The pancreas is an integral part of the digestive system, and the flow of the digestive system is often altered during the surgical treatment of pancreatic cancer. Therefore it is helpful to review the normal flow of food and the flow of digestive enzymes of the pancreas before reading about surgical treatment.
Food is carried from the mouth to the stomach by the esophagus. The esophagus is a tube that descends from the mouth down into the abdomen. In the abdomen, the esophagus empties into the stomach where digestive acids made by the stomach break down the food. From the stomach, the partially digested food flows directly into the first part of the small intestine, called the duodenum. It is here in the duodenum that bile from the liver and digestive enzymes from the pancreas enter the digestive system.
The duodenum then leads to the other parts of the small bowel, the jejunum and ileum, where further digestion of food takes place. The ileum then empties into the large bowel (also known as the large intestine), and finally completely digestive material passes out of the body through the anus.
What is bile?
Bile is important to understand because the flow of bile is often blocked by pancreatic cancers, and because the flow of bile is altered during surgery for pancreatic cancer. Bile is a greenish-yellow fluid that aids in the digestion of fats in food. After being produced by cells in the liver, the bile travels down through the bile ducts which merge with the cystic duct from the gallbladder to form the common bile duct. The gallbladder stores extra bile until needed. The common bile duct then passes through the head of the pancreas and joins the pancreatic duct to form the ampulla of Vater which then empties into the duodenum. The flow of bile is indicated by the green arrows.
Understanding that the tube (duct) carrying bile from the liver passes through the pancreas on its way to the intestine, helps us understand why some people with pancreatic cancer develop jaundice (an abnormal yellowing of the skin and eyes). Pancreatic cancers in the head of the pancreas (the bile duct passes through the head of the pancreas) can block the bile duct and in so doing can block the flow of bile out of the liver. The bile backs up and causes jaundice.
What is pancreatic fluid?
Instead of carrying bile, the pancreatic duct carries the fluid containing the digestive enzymes produced by the acinar cells (exocrine cells) of the pancreas. The main pancreatic duct is normally only one-sixteenth of an inch in diameter and it has many small side branches. The main pancreatic duct merges with the bile duct in the head of the pancreas to form the ampulla of Vater (a widening of the duct just before it enters the duodenum). Just as was true for bile, the flow of pancreatic fluid is often blocked by tumors of the pancreas, and altered by pancreatic surgery. The flow of pancreatic fluid is indicated by the dark yellow arrow.
1. Fernandez-del Castillo C, Adsay NV. Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 2010; 139:708–713. [PubMed]
2. Charlesworth M, Verbeke CS, Falk GA, et al. Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature. J Gastrointest Surg 2012; 16:1422–1428. [PubMed]
3. Giudici F, Nesi G, Brandi ML, et al. Surgical management of insulinomas in multiple endocrine neoplasia type 1. Pancreas 2012; 41:547–553. [PubMed]
4. Del Chiaro M, Verbeke C, Salvia R, et al. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis 2013; 45:703–711. [PubMed]
5. Heidt DG, Burant C, Simeone DM. Total pancreatectomy: indications, operative technique, and postoperative sequelae. J Gastrointest Surg 2007; 11:209–216. [PubMed]
6. Bramis K, Gordon-Weeks AN, Friend PJ, et al. Systematic review of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Br J Surg 2012; 99:761–766. [PubMed]
7. Murphy MM, Knaus WJ, II, Ng SC, et al. Total pancreatectomy: a national study. HPB (Oxford) 2009; 11:476–482. [PMC free article][PubMed]
8. Stauffer JA, Nguyen JH, Heckman MG, et al. Patient outcomes after total pancreatectomy: a single centre contemporary experience. HPB (Oxford) 2009; 11:483–492. [PMC free article][PubMed]
9. Siassi M, Klein P, Hohenberger W. Organ-preserving surgery for multicentric carcinoma of the pancreas. Eur J Surg Oncol 1999; 25:548–550. [PubMed]
10. Slezak LA, Andersen DK. Pancreatic resection: effects on glucose metabolism. World J Surg 2001; 25:452–460. [PubMed]
11. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138:8–13. [PubMed]
12. Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 2007; 142:20–25. [PubMed]
13. Buchler MW, Wagner M, Schmied BM, et al. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 2003; 138:1310–1314. [PubMed]
14. Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007; 142:761–768. [PubMed]
15. Diabetes mellitus. Report of a WHO study group. Technical Report Series 646. 1980; http://whqlibdoc.who.int/trs/WHO_TRS_727.pdf Accessed November 3, 2016.
16. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21:2191–2192. [PubMed]
17. Fujita Y, Kozawa J, Iwahashi H, et al. Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area. Endocrine J 2015; 62:329–337. [PubMed]
18. Thibault V, Morisset AS, Brown C, et al. The increase in serum 25-hydroxyvitamin D following weight loss does not contribute to the improvement in insulin sensitivity, insulin secretion and beta-cell function. Br J Nutr 2015; 114:161–168. [PubMed]
19. Lloyd FP, Jr, Kang J. Multifocal papillary-cystic neoplasm of the pancreas. J Natl Med Assoc 2003; 95:1204–1207. [PMC free article][PubMed]
20. Miura F, Takada T, Amano H, et al. Middle-segment-preserving pancreatectomy. J Am Coll Surg 2007; 204:720–722. [PubMed]
21. Partelli S, Boninsegna L, Salvia R, et al. Middle-preserving pancreatectomy for multicentric body-sparing lesions of the pancreas. Am J Surg 2009; 198:e49–e53. [PubMed]
22. Matsubayashi H, Uesaka K, Kanemoto H, et al. Multiple endocrine neoplasms and serous cysts of the pancreas in a patient with von Hippel-Lindau disease. J Gastrointest Cancer 2010; 41:197–202. [PubMed]
23. Ohzato H, Yamamoto T, Fukunaga M, et al. Middle-preserving pancreatectomy for multifocal metastatic renal cell carcinoma located in the head, body and tail of the pancreas. A case report. JOP 2010; 11:633–637. [PubMed]
24. Sperti C, Polizzi ML, Moro M, et al. Middle-preserving pancreatectomy: an interesting procedure for pancreas-sparing resection. JOP 2010; 11:258–261. [PubMed]
25. Chen HW, Wang FJ, Lai EC, et al. Middle-preserving pancreatectomy for synchronous ampullary carcinoma and solid-pseudopapillary tumor of distal pancreas. Int J Surg Case Rep 2011; 2:267–268. [PMC free article][PubMed]
26. Horiguchi A, Ishihara S, Ito M, et al. Middle-segment-preserving pancreatectomy for biliary-pancreatic tumors. Hepatogastroenterology 2011; 58:1018–1021. [PubMed]
27. Cheng K, Shen BY, Peng CH, et al. Middle-preserving pancreatectomy: report of two cases and review of the literature. World J Surg Oncol 2013; 11:106. [PMC free article][PubMed]
28. Nishi M, Kawasaki H, Fujii M, et al. Middle-preserving pancreatectomy for multifocal intraductal papillary mucinous neoplasms of the pancreas: report of a case. Clin J Gastroenterol 2014; 7:251–254. [PMC free article][PubMed]
29. Takeshi A, Mitsuhiro I, Hiromitsu A, et al. Middle segment-preserving pancreatectomy for recurrent metastasis of renal cell carcinoma after pancreatoduodenectomy: a case report. Case Rep Surg 2014; 2014:648678. [PMC free article][PubMed]
30. Tanemura A, Mizuno S, Okura Y, et al. Margin-negative limited resection of metastatic pancreatic tumors from rectal cancer preoperatively diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsies: report of two cases. Surg Today 2014; 44:366–372. [PubMed]
31. Usui M, Kuriyama N, Uchida K, et al. Laparoscopy assisted middle-segment-preserving pancreatectomy for multiple pancreatic neuroendocrine tumors: report of a case. Asian J Endosc Surg 2014; 7:271–274. [PubMed]
32. Chiang KC, Hsu JT, Chen HY, et al. Multifocal intraductal papillary mucinous neoplasm of the pancreas—a case report. World J Gastroenterol 2009; 15:628–632. [PMC free article][PubMed]
33. Goyal J, Lipson EJ, Rezaee N, et al. Surgical resection of malignant melanoma metastatic to the pancreas: case series and review of literature. J Gastrointest Cancer 2012; 43:431–436. [PMC free article][PubMed]
34. Konstantinidis IT, Dursun A, Zheng H, et al. Metastatic tumors in the pancreas in the modern era. J Am Coll Surg 2010; 211:749–753. [PMC free article][PubMed]
35. Minter RM, Reith JD, Hochwald SN. Metastatic potential of dermatofibrosarcoma protuberans with fibrosarcomatous change. J Surg Oncol 2003; 82:201–208. [PubMed]
36. Okano K, Murakami Y, Nakagawa N, et al. Remnant pancreatic parenchymal volume predicts postoperative pancreatic exocrine insufficiency after pancreatectomy. Surgery 2016; 159:885–892. [PubMed]